Abstract
Personalized medicine is a model for health care which is a combination of preventive, personalized, participatory and predictive measures. It is an approach for better treatment by identifying the disease causing genomic makeup of an individual. Personalized medicine is a broad field and it can be used for the diagnosis of various diseases like cancers, Alzheimer, Hepatitis, Cardiac diseases etc. It is an emerging field with lots of hope in the future. This review is basically based on characteristics of personalized medicine and its implementation in various diseases like lung cancer, renal cancer and rheumatoid arthritis. Further, the initiation taken by the European Union towards the development of personalized medicine and the challenges faced during the data collection, development of medicine and clinical trials were also discussed. The personalized medicine coalitions (PMC) have approved various novel medicines as personalized medicine under US FDA.
Original language | English |
---|---|
Pages (from-to) | 290-294 |
Number of pages | 5 |
Journal | International Journal of Pharmaceutical Quality Assurance |
Volume | 10 |
Issue number | 2 |
Early online date | 25 Jun 2019 |
DOIs | |
Publication status | Published online - 25 Jun 2019 |
Keywords
- Genome
- Lung cancer
- Personalized medicine
- Renal cancer
- Rheumatoid arthritis